We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 4,192 results
  1. Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T cells

    Conflicting hallmarks are attributed to cytomegalovirus (CMV) infections. CMVs are viewed as being master tacticians in “immune evasion” by...

    Sara Hamdan, Matthias J. Reddehase, Rafaela Holtappels in Medical Microbiology and Immunology
    Article Open access 01 April 2022
  2. Avidity in antibody effector functions and biotherapeutic drug design

    Antibodies are the cardinal effector molecules of the immune system and are being leveraged with enormous success as biotherapeutic drugs. A key part...

    Simone C. Oostindie, Greg A. Lazar, ... Paul W. H. I. Parren in Nature Reviews Drug Discovery
    Article 05 July 2022
  3. Impaired B Cell Recall Memory and Reduced Antibody Avidity but Robust T Cell Response in CVID Patients After COVID-19 Vaccination

    Purpose

    Humoral and cellular immune responses were described after COVID-19 vaccination in patients with common variable immunodeficiency disorder...

    Sophie Steiner, Tatjana Schwarz, ... Leif G. Hanitsch in Journal of Clinical Immunology
    Article Open access 17 March 2023
  4. The quantity and quality of anti-SARS-CoV-2 antibodies show contrariwise association with COVID-19 severity: lessons learned from IgG avidity

    Gaining more appreciation on the protective/damaging aspects of anti-SARS-CoV-2 immunity associated with disease severity is of great importance....

    Mehrdad Hajilooi, Fariba Keramat, ... Ghasem Solgi in Medical Microbiology and Immunology
    Article 27 April 2023
  5. HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial

    The HPV vaccine has shown sustained efficacy and consistent stabilization of antibody levels, even after a single dose. We defined the HPV16-VLP...

    Sabrina H. Tsang, John T. Schiller, ... Mark H. Stoler in npj Vaccines
    Article Open access 29 March 2022
  6. Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants

    Differences in innate immune ‘imprinting’ between vaccine adjuvants may mediate dissimilar effects on the quantity/quality of persisting adaptive...

    Sonia Budroni, Francesca Buricchi, ... Wivine Burny in npj Vaccines
    Article Open access 21 May 2021
  7. Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection

    RTS,S/AS01 is an advanced pre-erythrocytic malaria vaccine candidate with demonstrated vaccine efficacy up to 86.7% in controlled human malaria...

    Kelly E. Seaton, Rachel L. Spreng, ... S. Moses Dennison in npj Vaccines
    Article Open access 30 August 2021
  8. Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques

    Malaria transmission-blocking vaccines candidates based on Pfs25 and Pfs230 have advanced to clinical studies. Exoprotein A (EPA) conjugate of Pfs25...

    Puthupparampil V. Scaria, Charles Anderson, ... Patrick E. Duffy in npj Vaccines
    Article Open access 09 December 2021
  9. Measuring antibody avidity to Plasmodium falciparum merozoite antigens using a multiplex immunoassay approach

    Background

    Antibodies (Ab) play a significant role in immunity to Plasmodium falciparum malaria. Usually, following repeated exposure to pathogens,...

    Diane Wallace Taylor, Naveen Bobbili, ... Rose F. G. Leke in Malaria Journal
    Article Open access 01 May 2020
  10. Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies

    T cells are fundamental components in tumour immunity and cancer immunotherapies, which have made immense strides and revolutionized cancer treatment...

    Minghua **ang, Huayi Li, ... Yong Fang in Molecular Cancer
    Article Open access 05 April 2024
  11. Comparative analyses of functional antibody-mediated inhibition with anti-circumsporozoite monoclonal antibodies against transgenic Plasmodium berghei

    Background

    Acquired functional inhibitory antibodies are one of several humoral immune mechanisms used to neutralize foreign pathogens. In vitro...

    Justin Nicholas, Surendra Kumar Kolli, ... John H. Adams in Malaria Journal
    Article Open access 07 November 2023
  12. Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans

    Adjuvants can alter the magnitude, characteristics, and persistence of the humoral response to protein vaccination. HIV vaccination might benefit...

    Shiwei Xu, Margaret C. Carpenter, ... Margaret E. Ackerman in npj Vaccines
    Article Open access 04 August 2022
  13. Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan

    CD8 + T cells provide robust antiviral immunity, but how epitope-specific T cells evolve across the human lifespan is unclear. Here we defined CD8 + T...

    Carolien E. van de Sandt, Thi H. O. Nguyen, ... Katherine Kedzierska in Nature Immunology
    Article Open access 25 September 2023
  14. Natural LILRB1 D1-D2 variants show frequency differences in populations and bind to HLA class I with various avidities

    Leukocyte immunoglobulin-like receptor B1 (LILRB1) is widely expressed on various immune cells and the engagement of LILRB1 to HLA class I and...

    Fuguo Liu, Alexander T. H. Cocker, ... Lisbeth A. Guethlein in Immunogenetics
    Article 13 May 2022
  15. Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry

    Variants of uncertain significance (VUS) in CTLA4 are frequently identified in patients with antibody deficiency or immune dysregulation syndromes...

    Jessica Rojas-Restrepo, Elena Sindram, ... Laura Gámez-Díaz in Journal of Clinical Immunology
    Article Open access 23 September 2023
  16. An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

    NP 105–113 -B*07:02-specific CD8 + T cell responses are considered among the most dominant in SARS-CoV-2-infected individuals. We found strong...

    Yanchun Peng, Suet Ling Felce, ... Tao Dong in Nature Immunology
    Article Open access 01 December 2021
  17. Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults

    Background

    Immune responses to COVID-19 mRNA vaccines have not been well characterized in frail older adults. We postulated that frailty is associated...

    Charles T. Semelka, Michael E. DeWitt, ... Martha A. Alexander-Miller in Immunity & Ageing
    Article Open access 17 January 2023
  18. Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccines

    Zoster vaccines generate antibody responses against varicella-zoster virus (VZV). We compared antibody-dependent cell cytotoxicity (ADCC) elicited by...

    Seong Yeon Park, Myron J. Levin, ... Adriana Weinberg in npj Vaccines
    Article Open access 25 October 2022
  19. Divergent clonal differentiation trajectories of T cell exhaustion

    Chronic antigen exposure during viral infection or cancer promotes an exhausted T cell (Tex) state with reduced effector function. However, whether...

    Bence Daniel, Kathryn E. Yost, ... Ansuman T. Satpathy in Nature Immunology
    Article 26 October 2022
Did you find what you were looking for? Share feedback.